Archived App (Last seen on 13 May 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
Chronic Tirzepatide Dose in the Maintenance of Body Weight Reduction in
Participants Who Have Obesity or Overweight with Weight-Related Comorbidities. This app is specifically intended for site users in the I8F-MC-GPIQ study only.
Show more
What's New in I8F
1.1
September 5, 2023
Minor bug fix.
